Just Give Me Positive Good News
  • Home
  • Good News
  • Home
  • Good News

JUST POSITIVE GOOD NEWS ABOUT COVID-19

There is so much negativity in the news about COVID-19, we want to give you all the positive good news that is happening with research, clinical trials, improvements and anything that we can be positive about that you may not have seen.

IF YOU JUST WANT FEEL GOOD, INSPIRING STORIES AND VIDEOS THEN LOOK AT OUR NEW PAGE HERE

Pfizer, BioNTech Vaccine Trial Remains on Track, CEO Says

10/15/2020

 
Side effects that have emerged in a large late-stage trial of a Covid-19 vaccine candidate from Pfizer Inc. and BioNTech SE are in line with those seen in smaller early studies, a positive sign for one of the front-runners in the race for a shot.

The partners haven’t had to stop their late-stage study over safety concerns, BioNTech Chief Executive Officer Ugur Sahin said in an interview. They’re sticking with their previously announced target of being able to provide preliminary data on whether the vaccine works as soon as this month, if a threshold for infections is reached; if so, any submissions for regulatory approval would come later.

That would put Pfizer and BioNTech on track to potentially be the first to show the efficacy of a Covid-19 vaccine, in an environment of intense scrutiny over every possible complication. This week, Eli Lilly & Co. and Johnson & Johnson both said they had to pause research on potential therapies or shots because of safety concerns. Meanwhile, U.S. President Donald Trump has touted unproven treatments and pushed for more rapid regulatory review.

The pauses in other studies show “there is no room for ignoring facts,” Sahin said. “If there is a concern, the process stops. No one closes their eyes, and it should give people confidence that if a vaccine survives the development process and is approved, it should be regarded as safe.”

With just 195 participants, the early study was too small to show the real safety implications of the experimental shot. Still, the side effects that have emerged so far in the 44,000-person late-stage trial are similar to those seen in these early studies, Sahin said.

Safety is a key factor for any potential vaccine because the shots will be given widely to healthy people. The Food and Drug Administration has said it will require two months of safety data before reviewing any application for emergency authorization for a vaccine.

Collecting the extra safety data probably won’t cause much of a delay once readout on the vaccine’s effectiveness is available, Sahin said.

“Waiting another couple of weeks to complete the safety data should not be a concern,” he said.

https://www.bloomberg.com/news/articles/2020-10-14/pfizer-biontech-covid-vaccine-trial-remains-on-track-ceo-says

HELP US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you've enjoyed the site we'd love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.

ENJOY FEEL GOOD, INSPIRING STORIES AND VIDEOS ?

Our new page here is just what you need, with just good news, feel good stories unrelated to COVID.

Comments are closed.

    Who Am I ?

    Just someone trying to highlight the positive news amongst a sea of negativity.


    Archives

    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020

    Categories

    All
    Australia
    Austria
    Brazil
    Canada
    China
    Clinical Trials
    Companies
    Denmark
    Education
    France
    Germany
    Greece
    India
    Ireland
    Italy
    Lockdown
    Netherlands
    New Zealand
    Portugal
    PPE
    Reopen
    South Korea
    Spain
    Statistics
    Summary
    Switzerland
    Testing
    Treatment
    Turkey
    UK
    USA
    Vaccine
    Ventilators

    RSS Feed

Proudly powered by Weebly